News About: Goverment
WithPharm official wanted for embezzlement
WithPharm said on August 6 it plans to sue an official who allegedly embezzled its official funds by using his position at the company.
He allegedly attracted funds from the dishonored bill to invest in real estate...
KFDA approved Novartis' Lucentis, a vision recovery therapy.
The KFDA has approved Lucentis (ranibizumab) injectable drug filed by Novartis Korea for the treatment of wet age-related macular degeneration (AMD), which will be the first therapeutic drug ever sold in Korea.
AMD...
Health ministry to improve domestic R&D environmentThe Ministry of Health and Welfare unveiled the plan on July 26 to encourage the research and development (R&D) activities of domestic pharmaceutical firms after screening their...
|
Generic drug prices to fall by 20 percent on average
When a generic drug gets listed for insurance coverage, the price of the corresponding drug will be determined by 80 to 100 percent versus the original drug, the Ministry of Health and Welfare said on July 24.
Und...
Roh names new KFDA vice commissionerPresident Roh Moo-hyun on July 24 nominated Vice Commissioner of the Korea Food and Drug Administration Moon Byung-woo for the KFDA's second post.
Moon, 56, will replace Kim ...
|
Chief NITR commissioner Choi Soo-young may work at KRPIA.
Mr. Choi Soo-young, the chief commissioner of National Institute for Toxicological Research will finish his official career on Aug. 31 and may move to the KRPIA, a foreign multinational drug corporation association of...
Drug wholesaler licence issuance transferred to local governors.
The issuance of the wholesale business licences for drugs, herbal drugs and veterinary drugs will be transferred from the MOHW to the local governors, city mayor, country and district governors.
Government relocati...
Korea sees tough talks with EU FTA on pharmaceuticals
Free trade negotiations between Korea and the European Union are expected to be tough on pharmaceutical sector, government officials said.
The EU has demanded the extension of the expiration date for patents on new...
SK's "M-vix", an erectile dysfunction therapy, to market in Korea.
Following a serial market launching of the drugs for erectile dysfunction therapy by Pfizer, Lilly, Bayer, Dong-A and CKD, SK Chemical seems to enter this annual 80 billion won of markets (as of 2006) very soon.
T...
EU demands more wider access to domestic pharmaceutical sector
Negotiations with the European Union are likely to be tougher than expected also because of Brussels' interest in wider access to Korea's pharmaceutical sector.
"In pharmaceuticals, the EU's call to open up Korea i...
